GlassScriptPhysician profile
Augustus Caine
NPI 1043657844
$1,507.02
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $97.77 · 2021: $143 · 2022: $13.26 · 2023: $501 · 2024: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.47 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $223.41 | 2019-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.63 | 2019 | |
| Pfizer INC. | $209.40 | 2019-2023 | |
| Abiomed | $138.95 | 2024 | Impella |
| Biotronik INC. | $87.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $79.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $72.59 | 2023 | |
| Boston Scientific Corporation | $57.25 | 2022-2023 | Watchman Flx |
| Amgen INC. | $37.05 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $28.88 | 2023 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $24.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.86 | 2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $19.12 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $18.76 | 2023 | Inpefa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $16.75 | 2023 | Arcalyst |
| Janssen Scientific Affairs, LLC | $15.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustus Caine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.